Bd advances "one-stick hospital stay" vision with launch of next-generation needle-free blood draw technology

New peripheral line draw solution delivers first and only compatibility with integrated catheters, bringing elevated standard of care to more u.s. hospitals   franklin lakes, n.j. , nov. 2, 2023 /prnewswire/ -- bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company, today launched new needle-free blood draw technology compatible with integrated catheters, helping to further enable the company's vision of a "one-stick hospital stay.
BDX Ratings Summary
BDX Quant Ranking